GR – Novartis & Novartis Hellas v. GPH

Posted: February 16th, 2017

Novartis AG & Novartis Hellas SA v. GPH Ltd, Greece , First Instance Court of Athens (temporary relief proceedings), 21 December 2016, Judgment No. 8512/2016 Novartis AG and its Greek subsidiary, Novartis Hellas,  initiated successful temporary relief proceedings against GPH Ltd in defense of their rights to EP No. 2292219 (EP 219), which covers a […]


UK – Jushi Group v. OCV Intellectual Capital

Posted: February 16th, 2017

Jushi Group Co., Ltd v OCV Intellectual Capital, LLC, Intellectual Property Enterprise Court (HHJ Hacon), 6 February 2017, Neutral Citation Number [2017] EWHC 171 (IPEC) This case is interesting for the approach taken by the UK court in a situation where the patent in suit claims ranges that overlap with ranges disclosed in the prior […]


UK – Wobben v Siemens / Appeal

Posted: February 10th, 2017

Wobben Properties GmbH v. Siemens plc & Ors, UK, Court of Appeal (Civil Division), Kitchin LJ, Longmore LJ, Floyd LJ, 19 January 2017, Neutral Citation Number: [2017] EWCA Civ 5 This is an appeal against the judgment of Birss J of 20 July 2015, in which he held that Wobben’s patent was invalid for lack […]


NO – EcoLice AS/Sea Lice Research Norway AS v. Sinkaberg-Hansen AS, Bindalslaks AS

Posted: January 16th, 2017

The proceedings concerned the validity of the Norwegian patent 330244, owned by Sea Lice Research Norway AS, and to which Ecolice had been granted a license. The patent was directed to a treatment against sea lice which is a major problem in Norwegian aquaculture. More precisely, claim 1 of the patent related to use of […]


UK – Hospira v. Genentech

Posted: January 10th, 2017

Hospira UK Limited v Genentech Inc., Court of Appeal, Lord Justice Longmore, Lord Justice Kitchin and Lord Justice Floyd, 30 November 2016 The Court of Appeal has upheld that the Swiss-form claim of Genentech’s patent relating to the use of the monoclonal antibody trastuzumab in combination with a taxane (paclitaxel) for the treatment of HER2-positive […]


UK – Novartis AG v Focus Pharmaceuticals UK

Posted: January 6th, 2017

Novartis Ag v Focus Pharmaceuticals UK Ltd, UK, Court of Appeal, Lord Justice Kitchin, Lord Justice Floyd and Lord Justice Hamblen, 21 December 2016 This judgement was an appeal from a decision of Mr Justice Arnold who had previously found Novartis’ patent for transdermal patches containing rivastigmine used to prevent, treat or delay the progression […]


UK – Teva UK v. Boehringer Ingelheim Pharma

Posted: December 28th, 2016

Teva UK Limited v Boehringer Ingelheim Pharma GmbH & Co KG, UK, Court of Appeal, Kitchin LJ and Floyd LJ, 16 December 2016 These proceedings concerned an application on behalf of Boehringer Ingelheim Pharma GmbH & Co (Boehringer) seeking permission of the Court of Appeal to appeal a decision by Morgan J to revoke Patent […]


UK – MSD v. Shionogi

Posted: December 21st, 2016

Merck Sharp and Dohme Limited v Shionogi & Co. Limited, High Court of England and Wales (Arnold J), 25 November 2015, Neutral Citation Number [2016] EWHC 2989 (Pat) The claimant, Merck, sought revocation of Shionogi’s EP(UK) 1 422 218. The defendant, Shionogi, counterclaimed for infringement by Merck’s integrase inhibitor raltegravir, marketed as Isentress. Shionogi made […]


NL – Hewlett-Packard v. Benson Image

Posted: December 13th, 2016

Hewlett-Packard Development Company, L.P. (“HP”) v. Benson Image B.V., Top Printing B.V. and Agiostar B.V. (“Benson”), District Court of The Hague, the Netherlands, 30 November 2016, Case number 504637 / HA ZA 16-125 HP is the owner of European Patent EP 01 737 669 for a ‘fluid ejection device’, applied for on 6 April 2005 […]